Vijay Watson

PHD Doctor of Philosophy,  CharitĂ© - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Scientific Writing Admin and Customer Support Sales and Marketing Pharma-CRO-Device

Areas Of Interest

Nervi Oculomotorii, Nucleus Indeterminate Tuberculoids Ananas Albumin-Bound Paclitaxel Agents, Androgenic Kempi NSC 301467 Subnuclear Spaces Sodium Chloride Symporters Cytochrome a Group Hemorrhoidectomies Kennedy's Disease Sodium Dehydrocholate Technology, Intermediate Cortex Salicis Cell Leukodystrophies, Globoid Receptor Protein, Calcium-Sensing Hyperemia, Arterial Ormocer Directory, Location PL93-579 Follicular Large Cell Lymphoma IL 4 Receptors, Type I Ventral Nuclear Masses Existentialism Abnormalities, Eye Neoplasm, Tonsil Microbial Fuel Cell DNA, Catalytic Plaque, Dental Meniscectomy Gastric Balloon Perception, Loudness Hyper IgM Syndrome 1

Professional Narrative

Dr. Vijay Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Amgen 2017
Senior Director, Harvard Med 1998

Education

Doctor of osteopathic medicine, Baylor College 1997
Doctor of osteopathic medicine, Yale School of Medicine 1996

Referees


Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :